Jones Financial Companies’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-70
Closed -$267 4296
2025
Q2
$267 Buy
+70
New +$275 ﹤0.01% 3883

Other funds holding HCAT

Jones Financial Companies's HCAT Position: Q3 2025 in Review

Jones Financial Companies sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 70 shares — an estimated $267 sold.

Jones Financial Companies first reported a position in HCAT in Q2 2025 and held it in 1 quarter. The position peaked at $267 in Q2 2025. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Jones Financial Companies reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Jones Financial Companies sold 70 Health Catalyst shares in Q3 2025, an estimated $267.
  • Jones Financial Companies first reported a position in Health Catalyst in Q2 2025 and held it in 1 quarter.
  • Jones Financial Companies's Health Catalyst position peaked at $267 in Q2 2025.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Jones Financial Companies's 13F filing for Q3 2025, filed 4 Nov 2025.